NanoString Technologies Inc
Prices are adjusted according to historical splits.
Vitals
- Today's Low:
- $1.61
- Today's High:
- $1.94
- Open Price:
- $1.66
- 52W Low:
- $1.61
- 52W High:
- $16.47
- Prev. Close:
- $1.67
- Volume:
- 1149393
Company Statistics
- Market Cap.:
- $79.40 million
- Book Value:
- -0.452
- Revenue TTM:
- $143.92 million
- Operating Margin TTM:
- -111.91%
- Gross Profit TTM:
- $61.79 million
- Profit Margin:
- -115.14%
- Return on Assets TTM:
- -28.66%
- Return on Equity TTM:
- -363.38%
Company Profile
NanoString Technologies Inc had its IPO on 2013-06-26 under the ticker symbol NSTG.
The company operates in the Healthcare sector and Medical Instruments & Supplies industry. NanoString Technologies Inc has a staff strength of 703 employees.
Stock update
Shares of NanoString Technologies Inc opened at $1.66 at the start of the last trading session i.e. 2023-09-12.
The stocks traded within a range of $1.61 - $1.94, and closed at $1.91.
This is a +14.37% increase from the previous day's closing price.
A total volume of 1,149,393 shares were traded at the close of the day’s session.
In the last one week, shares of NanoString Technologies Inc have slipped by -25.97%.
NanoString Technologies Inc's Key Ratios
NanoString Technologies Inc has a market cap of $79.40 million, indicating a price to book ratio of 4.2975 and a price to sales ratio of 2.8789.
In the last 12-months NanoString Technologies Inc’s revenue was $143.92 million with a gross profit of $61.79 million and an EBITDA of $-149308000. The EBITDA ratio measures NanoString Technologies Inc's overall financial performance and is widely used to measure its profitability.
In the trailing 12-month period, NanoString Technologies Inc’s operating margin was -111.91% while its return on assets stood at -28.66% with a return of equity of -363.38%.
In Q2, NanoString Technologies Inc’s quarterly earnings growth was a positive 0% while revenue growth was a positive 37.1%.
NanoString Technologies Inc’s PE and PEG Ratio
- Forward PE
- 0
- Trailing PE
- 0
- PEG
- 0
Its diluted EPS in the last 12-months stands at $-3.21 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of 0. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.
The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into NanoString Technologies Inc’s profitability.
NanoString Technologies Inc stock is trading at a EV to sales ratio of 2.7886 and a EV to EBITDA ratio of -2.9004. Its price to sales ratio in the trailing 12-months stood at 2.8789.
NanoString Technologies Inc stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.
Balance sheet and cash flow metrics
- Total Assets
- $288.99 million
- Total Liabilities
- $62.43 million
- Operating Cash Flow
- $24.31 million
- Capital Expenditure
- $5.69 million
- Dividend Payout Ratio
- 0%
NanoString Technologies Inc ended 2024 with $288.99 million in total assets and $0 in total liabilities. Its intangible assets were valued at $288.99 million while shareholder equity stood at $-21461000.00.
NanoString Technologies Inc ended 2024 with $4.84 million in deferred long-term liabilities, $62.43 million in other current liabilities, 5000.00 in common stock, $-894202000.00 in retained earnings and $0 in goodwill. Its cash balance stood at $114.31 million and cash and short-term investments were $117.60 million. The company’s total short-term debt was $5,440,000 while long-term debt stood at $227.38 million.
NanoString Technologies Inc’s total current assets stands at $221.45 million while long-term investments were $0 and short-term investments were $3.30 million. Its net receivables were $42.98 million compared to accounts payable of $20.87 million and inventory worth $48.85 million.
In 2024, NanoString Technologies Inc's operating cash flow was $24.31 million while its capital expenditure stood at $5.69 million.
Comparatively, NanoString Technologies Inc paid $0 in dividends in 2024.
Other key metrics
- Current Trading Price
- $1.91
- 52-Week High
- $16.47
- 52-Week Low
- $1.61
- Analyst Target Price
- $12.86
NanoString Technologies Inc stock is currently trading at $1.91 per share. It touched a 52-week high of $16.47 and a 52-week low of $16.47. Analysts tracking the stock have a 12-month average target price of $12.86.
Its 50-day moving average was $3.41 and 200-day moving average was $7.15 The short ratio stood at 6.15 indicating a short percent outstanding of 0%.
Around 164.4% of the company’s stock are held by insiders while 9560.6% are held by institutions.
Frequently Asked Questions About NanoString Technologies Inc
Similar Industry Stocks (Medical Instruments & Supplies)
Most Active
Top Gainers
Top Losers
About
NanoString Technologies, Inc. develops, manufactures, and sells technology for scientific and clinical information in the fields of genomics and proteomics in the Americas, Europe, the Middle East, and the Asia Pacific. The company offers nCounter Analysis System, an automated, multi-application, digital detection, and counting system. It provides nCounter Pro and FLEX systems that include Prep Station, an automated liquid handling component that processes and prepares samples for data collection; and nCounter Digital Analyzer, which collects data from samples by taking images of the immobilized fluorescent reporters in the sample cartridge and processing the data into output files. The company also offers nCounter SPRINT Profiler, an instrument that provides liquid handling steps and the digital analysis through use of a microfluidic cartridge; and nSolver Analysis Software, a data analysis program that enables researchers to check, normalize, and analyze their data. In addition, it provides custom CodeSets; panels with oncology, immunology and infectious disease, and neuroscience applications. Further, the company offers Master Kits, cartridges, ancillary reagents, tips and reagent plates to setup and process samples in instruments; and Prosigna in vitro diagnostic kits. The company is also developing GeoMx DSP system to enable the field of spatial biology. It has collaboration with Lam Research Corporation for the development of NGS sequencing platform and related assays; and Parker Institute for Cancer Immunotherapy to develop CAR-T regimens that enhances patient outcomes for various types of cancer, as well as collaboration with Stanford Medicine, Acrobat Genomics, and Illumina Accelerator to discover new drug targets for gene editing-based therapeutics. NanoString Technologies, Inc. was incorporated in 2003 and is headquartered in Seattle, Washington.